Skip to main content

LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.

Publication ,  Conference
Kelly, AT; Ambady, P; Brown, M; Butowski, N; Cavaliere, R; Curry, W; Desjardins, A; Franklin, L; Friedman, H; Gromeier, M; Jackson, L; Ong, S ...
Published in: CANCER RESEARCH
2021

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

13

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kelly, A. T., Ambady, P., Brown, M., Butowski, N., Cavaliere, R., Curry, W., … Nichols., G. (2021). LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma. In CANCER RESEARCH (Vol. 81).
Kelly, Andrea True, Prakash Ambady, Michael Brown, Nicholas Butowski, Robert Cavaliere, William Curry, Annick Desjardins, et al. “LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.” In CANCER RESEARCH, Vol. 81, 2021.
Kelly AT, Ambady P, Brown M, Butowski N, Cavaliere R, Curry W, et al. LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma. In: CANCER RESEARCH. 2021.
Kelly, Andrea True, et al. “LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.CANCER RESEARCH, vol. 81, no. 13, 2021.
Kelly AT, Ambady P, Brown M, Butowski N, Cavaliere R, Curry W, Desjardins A, Franklin L, Friedman H, Gromeier M, Jackson L, Mixson L, Ong S, Randazzo D, Sloan A, Wen P, Nichols. G. LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma. CANCER RESEARCH. 2021.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

13

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis